Edition:
United Kingdom

Pieris Pharmaceuticals Inc (PIRS.OQ)

PIRS.OQ on NASDAQ Stock Exchange Capital Market

5.67USD
5:01pm BST
Change (% chg)

$-0.08 (-1.39%)
Prev Close
$5.75
Open
$5.73
Day's High
$5.80
Day's Low
$5.67
Volume
31,137
Avg. Vol
156,126
52-wk High
$9.69
52-wk Low
$4.44

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 4.15 -0.174
FY 2017 Dec '17 18.15 0.167
Sep '17 3.93 -0.159
Jun '17 1.85 -0.232
Mar '17 1.34 -0.186
FY 2016 Dec '16 2.73 -0.152
Sep '16 0.79 -0.144
Jun '16 1.07 -0.144
Mar '16 1.25 -0.104
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 6 7.80 15.40 4.00 --
Quarter Ending Dec-18 6 8.57 18.40 4.00 0.00
Year Ending Dec-18 6 33.78 50.40 16.25 8.87
Year Ending Dec-19 6 22.25 40.00 12.00 7.20
Earnings (per share)
Quarter Ending Sep-18 6 -0.11 0.01 -0.19 -0.20
Quarter Ending Dec-18 6 -0.10 0.05 -0.20 -0.20
Year Ending Dec-18 6 -0.38 -0.15 -0.71 -0.81
Year Ending Dec-19 6 -0.79 -0.41 -1.14 -0.92
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 85.48 32.76
P/E High - Last 5 Yrs. -- 298.85 45.44
P/E Low - Last 5 Yrs. -- 91.59 24.26
Beta -- 0.93 0.89
Price to Sales (TTM) 41.16 112.69 5.73
Price to Book (MRQ) 29.26 14.09 5.45
Price to Tangible Book (MRQ) 29.57 14.67 7.05
Price to Cash Flow (TTM) -- 72.72 23.29
% Owned Institutions 50.96 14.42 2.21

Dividends

  Company industry sector
Dividend Yield -- 0.35 1.51
Dividend Yield - 5 Year Avg -- 0.27 1.52
Dividend 5 Year Growth Rate -- 1.70 5.22
Payout Ratio(TTM) -- 16.38 43.78

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 72.70 408.74 8.01
Sales (TTM) vs TTM 1 Yr. Ago 37.63 80.05 5.64
Sales - 5 Yr. Growth Rate -- 32.09 10.18
EPS (MRQ) vs Qtr. 1 Yr. Ago -61.36 29.06 20.60
EPS (TTM) vs TTM 1 Yr. Ago -69.16 -- --
EPS - 5 Yr. Growth Rate -- 39.56 10.66
Capital Spending - 5 Yr. Growth Rate -- 40.05 15.33

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.92 2.22
Current Ratio (MRQ) 2.87 5.50 3.03
LT Debt to Equity (MRQ) 0.00 25.57 12.39
Total Debt to Equity (MRQ) 0.00 27.28 16.72
Interest Coverage (TTM) -92.13 -101.33 32.64

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 39.25 54.37
Gross Margin - 5 Yr. Avg. -- 50.67 52.17
EBITD Margin (TTM) -417.27 -- --
EBITD - 5 Yr. Avg -- -588.18 10.81
Operating Margin (TTM) -424.61 -734.89 4.57
Operating Margin - 5 Yr. Avg. -- -609.81 6.23
Pre-Tax Margin (TTM) -445.15 -708.96 5.43
Pre-Tax Margin - 5 Yr. Avg. -- -613.30 6.67
Net Profit Margin (TTM) -459.70 -710.36 1.73
Net Profit Margin - 5 Yr. Avg. -- -616.33 2.94
Effective Tax Rate (TTM) -- 23.27 23.11
Effective Tax Rate - 5 Yr. Avg. -- 18.59 23.98

Efficiency

  Company industry sector
Revenue/Employee (TTM) 136,884 23,066,163 860,414,701
Net Income/Employee (TTM) -629,254 3,124,085 101,211,889
Receivable Turnover (TTM) -- 20.78 5.87
Inventory Turnover (TTM) -- 2.48 3.41
Asset Turnover (TTM) 0.09 0.41 0.94

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -40.46 0.33 11.14
Return on Assets - 5 Yr. Avg. -- 3.75 12.40
Return on Investment (TTM) -55.96 2.29 14.61
Return on Investment - 5 Yr. Avg. -- 2.93 16.14
Return on Equity (TTM) -132.26 3.86 16.34
Return on Equity - 5 Yr. Avg. -- 4.40 17.40
  1 Year 3 Year 5 Year
Sales % 98.87 -22.30 --
EPS (TTM) % -33.71 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Pieris Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 64.31%
# of Holders: 152
Total Shares Held: 34,722,988
3 Mo. Net Change: -91,417
# New Positions: 3
# Closed Positions: 2
# Increased Positions: 10
# Reduced Positions: 5
# Net Buyers: 5
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.